BioLineRx will present at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
Dec 12, 2021
Oral Presentation
Title: Motixafortide (BL-8040) and G-CSF Versus Placebo and G-CSF to Mobilize Hematopoietic Stem Cells for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: The GENESIS Trial
Date: Sunday, December 12, 2021
Time: 12:00 PM
Location: Georgia World Congress Center, Hall A1
Poster Presentations
Title: Autologous Hematopoietic Cell Transplantation with Higher Doses of CD34+ Cells and Specific CD34+ Subsets Mobilized with Motixafortide and/or G-CSF is Associated with Rapid Engraftment – A Post-hoc Analysis of the GENESIS Trial
Date: Sunday, December 12, 2021
Time: 6:00 PM - 8:00 PM
Title: The High Affinity CXCR4 Inhibitor, BL-8040, Impairs the Infiltration, Migration, Viability and Differentiation of Regulatory T Cells
Date: Sunday, December 12, 2021
Time: 6:00 PM - 8:00 PM
Title: Immunophenotypic and Single-Cell Transcriptional Profiling of CD34+ Hematopoietic Stem and Progenitor Cells Mobilized with Motixafortide (BL-8040) and G-CSF Versus Plerixafor and GCSF Versus Placebo and G-CSF: A Correlative Study of the GENESIS Trial
Date: Monday, December 13, 2021
Time: 6:00 PM - 8:00 PM
